Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20377 | 401 | 28.6 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
233 | 19645 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GENITAL GVHD | Author keyword | 6 | 100% | 1% | 4 |
2 | CARDIAC LATE EFFECTS | Author keyword | 2 | 67% | 0% | 2 |
3 | HCT HEMATOPOIETIC CELL TRANSPLANTATION | Author keyword | 2 | 67% | 0% | 2 |
4 | HEMATOL STEM CELL TRANSPLANTAT SECT MED | Address | 2 | 67% | 0% | 2 |
5 | AUSTRALASIAN BONE MARROW TRANSPLANT RECIPIENT REG | Address | 1 | 100% | 0% | 2 |
6 | BLOOD MARROW TRANPLANT PROGRAM | Address | 1 | 100% | 0% | 2 |
7 | GYNECOLOGICAL COMPLICATIONS | Author keyword | 1 | 100% | 0% | 2 |
8 | LONG TERM FOLLOW UP TRANSPLANT CLIN HEMATOL O | Address | 1 | 100% | 0% | 2 |
9 | LONG TERM FOLLOW UP UNIT | Address | 1 | 100% | 0% | 2 |
10 | MALIGNANT COMPLICATIONS | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GENITAL GVHD | 6 | 100% | 1% | 4 | Search GENITAL+GVHD | Search GENITAL+GVHD |
2 | CARDIAC LATE EFFECTS | 2 | 67% | 0% | 2 | Search CARDIAC+LATE+EFFECTS | Search CARDIAC+LATE+EFFECTS |
3 | HCT HEMATOPOIETIC CELL TRANSPLANTATION | 2 | 67% | 0% | 2 | Search HCT+HEMATOPOIETIC+CELL+TRANSPLANTATION | Search HCT+HEMATOPOIETIC+CELL+TRANSPLANTATION |
4 | GYNECOLOGICAL COMPLICATIONS | 1 | 100% | 0% | 2 | Search GYNECOLOGICAL+COMPLICATIONS | Search GYNECOLOGICAL+COMPLICATIONS |
5 | MALIGNANT COMPLICATIONS | 1 | 100% | 0% | 2 | Search MALIGNANT+COMPLICATIONS | Search MALIGNANT+COMPLICATIONS |
6 | VAGINAL AGGLUTINATION | 1 | 100% | 0% | 2 | Search VAGINAL+AGGLUTINATION | Search VAGINAL+AGGLUTINATION |
7 | VAGINAL STENOSIS | 1 | 19% | 1% | 4 | Search VAGINAL+STENOSIS | Search VAGINAL+STENOSIS |
8 | ANTINUCLEOLAR ANTIBODY | 1 | 50% | 0% | 1 | Search ANTINUCLEOLAR+ANTIBODY | Search ANTINUCLEOLAR+ANTIBODY |
9 | CARDIOTOXITY | 1 | 50% | 0% | 1 | Search CARDIOTOXITY | Search CARDIOTOXITY |
10 | DONOR DERIVED CELL | 1 | 50% | 0% | 1 | Search DONOR+DERIVED+CELL | Search DONOR+DERIVED+CELL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SOLID CANCERS | 24 | 43% | 11% | 43 |
2 | CYCLOPHOSPHAMIDE CARDIOTOXICITY | 9 | 67% | 2% | 8 |
3 | SECONDARY MALIGNANCIES | 6 | 29% | 4% | 18 |
4 | 2 YEAR SURVIVORS | 6 | 100% | 1% | 4 |
5 | EFFECTS WORKING PARTY | 3 | 57% | 1% | 4 |
6 | VAGINAL STENOSIS | 1 | 33% | 1% | 3 |
7 | JOINT RECOMMENDATIONS | 1 | 40% | 0% | 2 |
8 | PREVENTIVE PRACTICES | 1 | 17% | 1% | 4 |
9 | CARDIAC FUNCTIONS | 1 | 50% | 0% | 1 |
10 | DOSE CYCLOPHOSPHAMIDE THERAPY | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Surviving the cure: long term followup of hematopoietic cell transplant recipients | 2013 | 12 | 25 | 60% |
Long-Term Follow-up After Allogeneic Stem Cell Transplantation | 2015 | 2 | 55 | 29% |
Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD | 2015 | 1 | 67 | 28% |
Severe vaginal chronic graft-versus-host disease (GVHD) two cases with late onset and literature review | 2010 | 5 | 4 | 100% |
Lost in Transition: The Essential Need for Long-Term Follow-Up Clinic for Blood and Marrow Transplantation Survivors | 2015 | 1 | 57 | 25% |
Delivering Care to Long-Term Adult Survivors of Hematopoietic Cell Transplantation | 2012 | 15 | 54 | 33% |
How I treat late effects in adults after allogeneic stem cell transplantation | 2011 | 20 | 74 | 31% |
Oral carcinoma after hematopoietic stem cell transplantation - a new classification based on a literature review over 30 years | 2009 | 10 | 30 | 60% |
Eruptive Disseminated Superficial Basal Cell Carcinomas 24 Years after Bone Marrow Transplantation | 2015 | 0 | 9 | 78% |
Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation | 2008 | 31 | 116 | 25% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEMATOL STEM CELL TRANSPLANTAT SECT MED | 2 | 67% | 0.5% | 2 |
2 | AUSTRALASIAN BONE MARROW TRANSPLANT RECIPIENT REG | 1 | 100% | 0.5% | 2 |
3 | BLOOD MARROW TRANPLANT PROGRAM | 1 | 100% | 0.5% | 2 |
4 | LONG TERM FOLLOW UP TRANSPLANT CLIN HEMATOL O | 1 | 100% | 0.5% | 2 |
5 | LONG TERM FOLLOW UP UNIT | 1 | 100% | 0.5% | 2 |
6 | STEM CELL TRANSPLANTAT SECT | 1 | 23% | 0.7% | 3 |
7 | CHILDHOOD HEMATOL ONCOL | 1 | 50% | 0.2% | 1 |
8 | COLORADO BLOOD CANC | 1 | 50% | 0.2% | 1 |
9 | CRCNIH | 1 | 50% | 0.2% | 1 |
10 | DENT AMBULATORY HEMATOL BLOOD TRANSFUS | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000206627 | FACT BMT//PEDIATRIC SCT//PSYCHOL CONSULTAT LIAISON PSYCHIAT |
2 | 0.0000203769 | IDIOPATHIC PNEUMONIA SYNDROME//BRONCHIOLITIS OBLITERANS//LATE ONSET NONINFECTIOUS PULMONARY COMPLICATIONS |
3 | 0.0000190900 | SEPTIC INFARCTION//ASPERGILLUS BRAIN ABSCESS//CD8CD57 CELLS |
4 | 0.0000170650 | ENDOCRINE LATE EFFECTS//GROWTH REPROD 5064//CRANIAL IRRADIATION |
5 | 0.0000125338 | TRANSPLANT RATES//EBMT ACT SURVEY OFF//OPERAT COMPUTAT FINANCE |
6 | 0.0000120032 | RADIATION NEPHROPATHY//SCHISTOCYTE//RADIATION NEPHRITIS |
7 | 0.0000119461 | SECONDARY LEUKEMIA//SECOND MALIGNANT NEOPLASM//THERAPY RELATED |
8 | 0.0000114918 | TOTAL BODY IRRADIATION//TOTAL MARROW IRRADIATION//OCULAR GRAFT VERSUS HOST DISEASE |
9 | 0.0000099896 | GRAFT VERSUS HOST DISEASE//CHRONIC GRAFT VERSUS HOST DISEASE//GVHD |
10 | 0.0000098369 | CARDIOTOXICITY//DEXRAZOXANE//DOXORUBICIN |